SOD2, ALDH2, MME and IGFBP1 expression

Biomarker

1 paper1 finding

  • Animals1

Associations

1

Metabolic dysfunction-associated steatohepatitis-related liver cancer

mixedin silico1

1 study
  1. Metabolic dysfunction-associated steatohepatitis-related liver cancer is associated with SOD2, ALDH2, MME and IGFBP1 expression in silico.

    “SOD2, ALDH2, MME and IGFBP1 which were belonged to SAGs were differential expressed in MRLC compared to paracancerous”

    In silicocompared with paracancerous tissueliver

    Multi omics analysis reveals senescence associated genes in metabolic dysfunction associated steatohepatitis related liver cancer and their functional validation

    International journal of biological macromolecules31 Mar 2026

More on Metabolic dysfunction-associated steatohepatitis-related liver cancer

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 1Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months